A detailed history of Dunhill Financial, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Dunhill Financial, LLC holds 30 shares of CTLT stock, worth $1,798. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Previous 26 15.38%
Holding current value
$1,798
Previous $1.47 Million 13.88%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$53.58 - $57.02 $214 - $228
4 Added 15.38%
30 $1.67 Million
Q1 2024

May 13, 2024

BUY
$42.56 - $59.82 $127 - $179
3 Added 13.04%
26 $1.47 Million
Q4 2023

Feb 12, 2024

BUY
$32.18 - $46.57 $740 - $1,071
23 New
23 $1.01 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.8B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Dunhill Financial, LLC Portfolio

Follow Dunhill Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dunhill Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dunhill Financial, LLC with notifications on news.